Henry Schein Stock Hits 52-Week High - Here's Why

Segment Performance - Global Distribution and Value-Added Services sales rose 7.0% to $2.89 billion in the fourth quarter, up 5.2% on a constant-currency basis from the year-ago period [1] - Global Specialty Products sales increased 14.6% to $422 million, or 11.1% in constant currency, driven by strong dental implant demand and solid growth in endodontics [1] - Global Technology sales climbed 8.4% to $173 million, up 7.6% in constant currency from the fourth quarter of 2024, reflecting accelerated adoption of cloud-based software and revenue from newly launched solutions [2] Management Commentary - The growth achieved, especially over the second half of 2025, demonstrates the effective execution of the 2025-2027 BOLD+1 strategic plan, positioning the company well for the future [3] Guidance - The company expects fiscal 2026 adjusted earnings of $5.23-$5.37 per share compared to the consensus of $5.30 [4] - Projected sales for 2026 are $13.58 billion-$13.84 billion, reflecting a year-over-year growth of 3% to 5% from fiscal 2025 sales of $13.18 billion [4] - 2026 adjusted EBITDA is expected to grow in mid-single digits compared with 2025 [5] Analyst View - Strength in the specialty segment is an encouraging sign for the company's ability to drive higher margin mix and for dental end-markets, given the specialty portfolio's high exposure to out-of-pocket procedures like dental implants [6] - Initial 2026 guidance is in line with or slightly ahead of the Street, indicating stability and improving results [6] - The first read on the quarter is viewed as a positive step with improving end-markets and execution on key segments like specialty products [6] HSIC Price Action - Henry Schein shares were up 5.01% at $83.57, trading at a new 52-week high [7]